| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |